Cargando…

Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma

Detalles Bibliográficos
Autores principales: Allmeroth, Kira, Horn, Moritz, Kroef, Virginia, Miethe, Stephan, Müller, Roman-Ulrich, Denzel, Martin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932915/
https://www.ncbi.nlm.nih.gov/pubmed/32690882
http://dx.doi.org/10.1038/s41375-020-0989-4
_version_ 1783660514211004416
author Allmeroth, Kira
Horn, Moritz
Kroef, Virginia
Miethe, Stephan
Müller, Roman-Ulrich
Denzel, Martin S.
author_facet Allmeroth, Kira
Horn, Moritz
Kroef, Virginia
Miethe, Stephan
Müller, Roman-Ulrich
Denzel, Martin S.
author_sort Allmeroth, Kira
collection PubMed
description
format Online
Article
Text
id pubmed-7932915
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79329152021-03-19 Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma Allmeroth, Kira Horn, Moritz Kroef, Virginia Miethe, Stephan Müller, Roman-Ulrich Denzel, Martin S. Leukemia Letter Nature Publishing Group UK 2020-07-20 2021 /pmc/articles/PMC7932915/ /pubmed/32690882 http://dx.doi.org/10.1038/s41375-020-0989-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Allmeroth, Kira
Horn, Moritz
Kroef, Virginia
Miethe, Stephan
Müller, Roman-Ulrich
Denzel, Martin S.
Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
title Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
title_full Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
title_fullStr Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
title_full_unstemmed Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
title_short Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma
title_sort bortezomib resistance mutations in psmb5 determine response to second-generation proteasome inhibitors in multiple myeloma
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932915/
https://www.ncbi.nlm.nih.gov/pubmed/32690882
http://dx.doi.org/10.1038/s41375-020-0989-4
work_keys_str_mv AT allmerothkira bortezomibresistancemutationsinpsmb5determineresponsetosecondgenerationproteasomeinhibitorsinmultiplemyeloma
AT hornmoritz bortezomibresistancemutationsinpsmb5determineresponsetosecondgenerationproteasomeinhibitorsinmultiplemyeloma
AT kroefvirginia bortezomibresistancemutationsinpsmb5determineresponsetosecondgenerationproteasomeinhibitorsinmultiplemyeloma
AT miethestephan bortezomibresistancemutationsinpsmb5determineresponsetosecondgenerationproteasomeinhibitorsinmultiplemyeloma
AT mullerromanulrich bortezomibresistancemutationsinpsmb5determineresponsetosecondgenerationproteasomeinhibitorsinmultiplemyeloma
AT denzelmartins bortezomibresistancemutationsinpsmb5determineresponsetosecondgenerationproteasomeinhibitorsinmultiplemyeloma